Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 858 | 218 | 117 | 7,000 | 233 |
| Gross Profit | 858 | 218 | 117 | 7,000 | 233 |
| Operating Expenses | 29,378 | 38,633 | 64,478 | 67,520 | 44,415 |
| Operating Income | -28,520 | -38,415 | -64,361 | -60,520 | -44,182 |
| Other Income | -134 | -3 | -111 | 28 | -14 |
| Pre-tax Income | -28,654 | -38,418 | -64,472 | -60,492 | -44,196 |
| Net Income Continuous | -28,654 | -38,418 | -64,472 | -60,492 | -44,196 |
| Net Income | $-28,654 | $-38,418 | $-64,472 | $-60,492 | $-44,196 |
| EPS Basic Total Ops | 1.95 | -22.34 | -37.63 | -69.12 | -312.44 |
| EPS Basic Continuous Ops | 2.11 | -22.34 | -37.69 | -69.17 | -312.52 |
| EPS Diluted Total Ops | 1.95 | -22.34 | -37.63 | -69.12 | -312.44 |
| EPS Diluted Continuous Ops | 2.11 | -22.34 | -37.69 | -69.17 | -312.52 |
| EBITDA(a) | $-27,583 | $-38,184 | $-64,167 | $-60,304 | $-43,983 |